While many AIs used to assist drug discovery are provided by big tech companies at a cost, a small US and China-based techbio ...

In another big-ticket licensing deal with a Chinese biotech, AstraZeneca has claimed rights to a drug candidate for chronic ...

The EU is asking for feedback on measures proposed by Sanofi to address concerns about a marketing campaign for a flu vaccine ...

Vera Therapeutics has won FDA approval for Trutakna, a BAFF/APRIL inhibitor for IgA nephropathy (IgAN) that will compete with ...

Marcus Evans announces The Evolution Summit, taking place September 28-29, 2026, at Park Hyatt Aviara Resort, Golf Club & Spa ...

Just weeks after forming as a spinout from Endevica Bio, obesity drug developer Kalohexis has filed for an IPO, whilst ...

Island Pharma has been granted the regulatory approvals needed to allow compassionate use of its antiviral galidesivir in the ...

Though they are still primarily prescribed for weight loss and diabetes, researchers are looking at the effects of GLP-1s for a wide variety of conditions from substance abuse dis ...

This month, the European Commission granted centralised marketing authorisation for Zandoriah (teriparatide), a biosimilar to ...

Women with endometriosis in England could soon be offered simple non-invasive tests for diagnosis of their condition, rather ...

Let me start with something most strategy decks dance around: the patent cliff isn't the problem. It's the symptom. Every ...

Vertex Pharma has made the largest acquisition in its history, agreeing to buy Crinetics Pharma for around $10 billion in a ...